Clinical Trial: Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer.

U.S., Oct. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07899697) titled 'Feasibility Study of Middle Segmental Gastrectomy (MSG) for Gastric Cancer.' on Oct. 07.

Brief Summary: This multicenter, prospective, single-arm phase 2 clinical trial aims to evaluate the safety, feasibility, and clinical applicability of Middle Segmental Gastrectomy (MSG) for patients with gastric cancer

* MSG is a function-preserving surgical technique that resects the middle portion of the stomach while preserving the pylorus and the upper stomach (cardia and fundus) to minimize common postoperative issues such as dumping syndrome and nutritional deficiencies

The primary objective of the study is to determine the incidence of...